A plain-language guide to the federally regulated drug test that every CDL driver and safety-sensitive employee will encounter — what it screens for, how collection works, and how results are verified.
The U.S. Department of Transportation requires a standardized urine panel for all regulated, safety-sensitive testing. Every DOT drug screen looks for the same five drug classes — no more, no less.
Whether you drive a commercial truck, operate heavy equipment, or hold any other safety-sensitive position covered under 49 CFR Part 40, the panel is identical nationwide. That consistency is the point: a collection done correctly in Houston means the same thing as one done anywhere else in the country. The five classes are:
Detects THC metabolites. Federal DOT rules do not recognize state-legal recreational or medical marijuana use as a valid explanation for a positive result.
Screens for cocaine metabolites such as benzoylecgonine, the marker the laboratory confirms before reporting a positive.
Includes amphetamine, methamphetamine, and the designer stimulants MDMA and MDA added to the federal panel.
Covers codeine, morphine, heroin (6-AM), and the semi-synthetics hydrocodone, hydromorphone, oxycodone, and oxymorphone.
Phencyclidine, the dissociative hallucinogen, rounds out the mandatory five-class federal panel.
Regulated employers must test in several defined situations. Knowing which one applies determines the deadline and the documentation you need.
Under the federal program — including the FMCSA rules at 49 CFR Part 382 for commercial drivers — testing is required for pre-employment, random selection, reasonable suspicion, return-to-duty, and follow-up testing. Post-accident testing has its own clock: alcohol testing should be conducted within 8 hours of a qualifying accident, and drug testing within 32 hours. After those windows close, the employer must stop attempting the test and document why it was not completed.
Random testing is handled through a consortium or pooled program that selects names by a scientifically valid method throughout the year. Owner-operators cannot select themselves and must belong to a consortium to stay compliant. You can read more about how that works on our random consortium management page.
A DOT collection is not a casual cup-and-go. It follows a tightly scripted chain-of-custody procedure designed to protect both the donor and the employer.
When a driver arrives, the collector verifies photo identification, secures personal belongings, and asks the donor to wash their hands. Water sources are restricted and bluing agent is added to the toilet so a specimen cannot be diluted or substituted. The donor provides a urine specimen of at least 45 mL, and the collector immediately checks its temperature — it must read between 90 and 100 degrees Fahrenheit within four minutes to confirm it is a fresh, valid sample.
The specimen is split into a primary and a secondary bottle, both sealed with tamper-evident labels that the donor initials. Everyone signs the Federal Custody and Control Form (CCF), and the sealed specimen is shipped to a laboratory certified by the federal Substance Abuse and Mental Health Services Administration. Our DOT urine drug testing collectors are DOT-qualified and follow this procedure on every collection, in our office or at your job site.
The laboratory runs an initial immunoassay screen. Anything that screens non-negative is automatically sent for a second, more precise confirmation test using gas or liquid chromatography-mass spectrometry before any positive is ever reported. A single screening hit is never the final word.
A laboratory positive does not go straight to the employer. Every result is first reviewed by a Medical Review Officer (MRO) — a licensed physician trained in substance-abuse testing. The MRO contacts the donor privately to ask whether there is a legitimate medical explanation, such as a valid prescription, that could account for the finding. Only after that review does the MRO report a verified result.
A verified negative clears the driver to perform safety-sensitive duties. A verified positive, a refusal, or an adulterated or substituted specimen removes the driver from those duties immediately and triggers the return-to-duty process through a Substance Abuse Professional. The driver may also request that the split (secondary) specimen be tested at a second laboratory within 72 hours of being notified.
For employers, the practical takeaway is simple: choose a collection partner that performs the procedure correctly the first time. A flawed collection can lead to a cancelled test and a repeat, which costs you time and keeps a driver off the road longer than necessary.